Cognitive Research Stack | Semax, Pinealon & NAD+ Multi-Target CNS Research

The Cognitive Research Stack assembles Semax, Pinealon, and NAD+ into a multi-target CNS research protocol covering three distinct biological dimensions of cognitive function: acute neurotrophic signaling, epigenetic neuroprotection, and neuronal energy metabolism. Each compound targets a non-overlapping mechanism, enabling researchers to study cognitive aging and neuroprotection across multiple biological levels within a single experimental design.

Cognitive Stack (Semax + Pinealon + NAD+): Research Overview

Cognitive aging research has moved beyond single-target interventions as the complexity of neurodegeneration has become better characterized. This three-compound stack reflects that shift, combining a neurotrophic factor inducer (Semax), an epigenetic neuroprotector (Pinealon), and a metabolic foundation compound (NAD+) into one protocol.

The combination has been studied across multiple CNS research contexts:

• BDNF and NGF Pathway Research: Semax upregulates brain-derived neurotrophic factor and nerve growth factor through melanocortin receptor pathways. Research in rodent models has examined effects on synaptic plasticity, hippocampal function, and memory consolidation. Pairing with NAD+ provides sirtuin-dependent epigenetic regulation that may influence BDNF expression long-term.
• Epigenetic Neuroprotection: Pinealon is a tripeptide developed by the Khavinson group that interacts with chromatin in neuronal cells. Research has documented effects on survival, oxidative defense, and aging-related gene expression. The combination with NAD+ creates a research context for studying epigenetic regulation at both peptide-chromatin and sirtuin-substrate levels.
• Neuronal Energy Metabolism: NAD+ supports mitochondrial biogenesis via PGC-1alpha, enables sirtuin-mediated deacetylation, and provides substrate for PARP-based DNA repair. In neurons, where metabolic demand is high and DNA damage accumulates with age, this metabolic foundation supports the conditions under which both Semax and Pinealon operate.
• Stroke and Ischemia Models: Semax has been investigated in rodent models of cerebral ischemia and stroke, with research examining infarct volume reduction and functional recovery. The combination with NAD+ adds a metabolic dimension to neuroprotection research, given the role of NAD+ depletion in ischemic neuronal death.

The individual components are also available as standalone products: Semax, Pinealon, and NAD+ 750mg. For the full research protocol writeup including synergy rationale and study citations, see the Cognitive Research Stack Protocol page.

Research Context: Cognitive Aging Research Landscape

The cognitive aging research field has converged on multi-target approaches as single-mechanism interventions have shown limited efficacy in age-related cognitive decline. BDNF-upregulation compounds, epigenetic neuroprotectors, and metabolic support agents represent three independent research lineages that have developed in parallel.

• Cognitive Research Stack (Semax + Pinealon + NAD+): Multi-target CNS stack covering neurotrophic, epigenetic, and metabolic mechanisms
• Semax: Standalone; ACTH(4-10) analog, BDNF/NGF upregulation, melanocortin receptor research
• Pinealon: Standalone; chromatin-interacting tripeptide, neuronal gene regulation
• NAD+ 750mg: Standalone; sirtuin substrate, mitochondrial biogenesis, PARP-mediated DNA repair
• Selank: Adjacent CNS research; anxiolytic, BDNF interaction (different receptor profile than Semax)

Related Research Resources

• Semax vs Selank: Nootropic Peptides Comparison
• Cognitive Peptides for Brain Fog 2026: Semax, NAD+, and Pinealon Research Guide
• Longevity Peptides: MOTS-c, Epithalon, NAD+ Cellular Aging Research
• Peptide Stacking Research Guide
• Cognitive Neuroprotection Research Area Hub

Key Properties

• Semax: A synthetic heptapeptide derived from the ACTH(4-10) sequence, with the structure Met-Glu-His-Phe-Pro-Gly-Pro. Developed by the Russian Academy of Sciences. Research has documented BDNF and NGF upregulation, melanocortin receptor interactions, and modulation of dopaminergic and serotonergic neurotransmission.
• Pinealon: A synthetic tripeptide with the sequence Glu-Asp-Arg, developed by the Khavinson group. Research has characterized its interaction with chromatin in neuronal cells, modulation of gene expression related to survival and antioxidant defense, and effects on neuronal aging models.
• NAD+ (Nicotinamide Adenine Dinucleotide): A coenzyme essential for sirtuin deacetylase activity, PARP-mediated DNA repair, and CD38-mediated calcium signaling. Cellular NAD+ levels decline with age across multiple tissue types including the central nervous system, making restoration a major research target in cognitive aging.
• Combined Research Applications: The three compounds operate on non-overlapping mechanisms. Semax modulates acute neurotrophic factor availability. Pinealon modulates the epigenetic state of neurons. NAD+ provides the metabolic foundation for both. Combination studies enable researchers to examine interactions between these three levels of cognitive biology.

Applications in Research

The Cognitive Research Stack supports laboratory studies in:

• Multi-target CNS research designs examining neurotrophic, epigenetic, and metabolic mechanisms simultaneously.
• BDNF and NGF pathway investigation, including melanocortin receptor signaling.
• Neuronal epigenetic regulation, chromatin interactions, and aging-related gene expression.
• NAD+ depletion and restoration research in neurons, including sirtuin and PARP pathways.
• Cerebral ischemia, stroke models, and neuroprotection research with multi-mechanism compounds.

All studies are conducted in controlled laboratory settings.

Storage and Handling Instructions

• Store Semax, Pinealon, and NAD+ in lyophilized form at 42°F (5°C) or lower, with long-term storage at -20°C or below.
• Protect from light, moisture, and excessive heat to preserve peptide and coenzyme stability.
• Reconstitute each component separately with sterile bacteriostatic water following research protocols.
• Use post-reconstitution solutions promptly and discard following institutional research procedures.

Safety Information

This product is intended for in vitro research purposes only. Laboratory personnel must:

• Follow institutional biosafety guidelines for handling and storage of research peptides.
• Use appropriate personal protective equipment during reconstitution and experimental work.
• Document all experimental protocols according to institutional review requirements.

Frequently Asked Questions

What does each compound contribute to the Cognitive Research Stack?

Semax contributes neurotrophic factor induction, specifically BDNF and NGF upregulation, which is relevant to synaptic plasticity and acute neuroprotection models. Pinealon contributes epigenetic gene regulation in neurons, modulating the expression of survival and oxidative defense genes in aging neuronal populations. NAD+ contributes the metabolic foundation by supporting sirtuin activity, PARP-based DNA repair, and mitochondrial biogenesis in neurons. Each compound targets a different biological level of the cognitive aging problem.

Is Semax primarily a cognitive enhancer or a neuroprotector in research literature?

Semax has documented effects in both cognitive performance models and neuroprotection contexts. In rodent models of ischemia and stroke, it has been studied for neuroprotective properties measured by infarct volume and functional outcomes. In non-injury cognitive models, it has been examined for memory consolidation, attention, and learning performance. The BDNF-upregulating mechanism is relevant to both contexts, since BDNF supports both neuronal survival and synaptic strengthening associated with memory formation.

Can NAD+ be replaced with MOTS-c in this stack?

MOTS-c could be added or substituted depending on the research question. MOTS-c addresses metabolic regulation and AMPK signaling, which is relevant to neuronal energy homeostasis but from a different mechanistic angle than NAD+. NAD+ is more directly relevant to neuronal DNA repair and sirtuin-mediated epigenetic regulation, making it the preferred choice for researchers focusing on the epigenetic and repair dimensions of cognitive aging. MOTS-c would be the preferred choice for researchers focusing on metabolic flexibility in neurons.

How does Pinealon differ from Semax in mechanism?

Pinealon and Semax operate on entirely different mechanistic pathways. Semax binds melanocortin receptors and acutely upregulates BDNF and NGF, producing neurotrophic effects within hours. Pinealon enters neuronal nuclei and interacts directly with chromatin, modulating gene expression patterns over longer time courses. Semax effects are predominantly acute and receptor-mediated. Pinealon effects are predominantly chronic and gene-regulatory.

What purity standards are required for research-grade Semax, Pinealon, and NAD+?

All three research compounds should demonstrate at least 98% purity as verified by HPLC analysis, with molecular identity confirmed by mass spectrometry. In-house purity testing ensures batch consistency. Researchers should verify purity documentation and batch-specific data before initiating any experimental protocol.

References

1. Levitskaya NG, Sebentsova EA, Andreeva LA, Alfeeva LY, Kamensky AA, Myasoedov NF. "Comparative analysis of the behavioral effects of the synthetic heptapeptide Semax and ACTH(4-10) heptapeptide." Neurosci Behav Physiol. 2002;32(4):355-360. PubMed: 12243246
2. Shadrina M, Kolomin T, Agapova T, Agniullin Y, Shram S, Slominsky P, Lymborska S, Myasoedov N. "Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action." J Mol Neurosci. 2010;41(1):30-35. PubMed: 19821145
3. Khavinson VK, Lin'kova NS, Tarnovskaya SI. "Short peptides regulate gene expression." Bull Exp Biol Med. 2016;162(2):288-292. PubMed: 27913908
4. Imai S, Guarente L. "NAD+ and sirtuins in aging and disease." Trends Cell Biol. 2014;24(8):464-471. PubMed: 24786309
5. Verdin E. "NAD+ in aging, metabolism, and neurodegeneration." Science. 2015;350(6265):1208-1213. PubMed: 26785480
6. Anisimov VN, Khavinson VK. "Peptide bioregulation of aging: results and prospects." Biogerontology. 2010;11(2):139-149. PubMed: 19543815